Stay updated on Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4 on the record history page, signaling a new version of the study record has been posted.
    Difference
    0.1%
    Check dated 2026-05-15T09:18:54.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The page’s interface revision was updated from v3.5.2 to v3.5.3, reflecting a maintenance/version change to the ClinicalTrials.gov site UI.
    Difference
    0.1%
    Check dated 2026-04-24T05:55:00.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The record history shows a revision bump from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:32:42.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added to the history and revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T06:11:58.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Revision history now shows v3.4.3 added and v3.4.2 removed.
    Difference
    0.1%
    Check dated 2026-03-12T02:21:42.000Z thumbnail image
  9. Check
    113 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history. The funding notice and Revision: v3.4.1 were removed.
    Difference
    0.4%
    Check dated 2026-02-11T11:30:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.